These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12271175)

  • 21. Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: a randomized, controlled study.
    Ashok PW; Flett GM; Templeton A
    Am J Obstet Gynecol; 2000 Oct; 183(4):998-1002. PubMed ID: 11035353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medical termination of pregnancy.
    Christin-Maitre S; Bouchard P; Spitz IM
    N Engl J Med; 2000 Mar; 342(13):946-56. PubMed ID: 10738054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two medical abortion regimens for late first-trimester termination of pregnancy: a prospective randomized trial.
    Dalenda C; Ines N; Fathia B; Malika A; Bechir Z; Ezzeddine S; Hela C; Badis CM
    Contraception; 2010 Apr; 81(4):323-7. PubMed ID: 20227549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current medical abortion care.
    Creinin MD
    Curr Womens Health Rep; 2003 Dec; 3(6):461-9. PubMed ID: 14613667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Women's voices and medical abortions: A review of the literature.
    Alam B; Kaler A; Mumtaz Z
    Eur J Obstet Gynecol Reprod Biol; 2020 Jun; 249():21-31. PubMed ID: 32348948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychological distress symptoms in women undergoing medical vs. surgical termination of pregnancy.
    Lowenstein L; Deutcsh M; Gruberg R; Solt I; Yagil Y; Nevo O; Bloch M
    Gen Hosp Psychiatry; 2006; 28(1):43-7. PubMed ID: 16377364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Misoprostol: off-label use in the first trimester of pregnancy (spontaneous abortion, and voluntary medical termination of pregnancy)].
    Beucher G; Dolley P; Carles G; Salaun F; Asselin I; Dreyfus M
    J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):123-45. PubMed ID: 24433988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Caring for women undergoing second-trimester medical termination of pregnancy.
    Andersson IM; Gemzell-Danielsson K; Christensson K
    Contraception; 2014 May; 89(5):460-5. PubMed ID: 24594432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Termination of pregnancy in the 2nd trimester: mifepriston/misoprostol preferable to sulprostone].
    Ebbers S; Creemers JW; Lotgering FK
    Ned Tijdschr Geneeskd; 2009; 153():A138. PubMed ID: 19930731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First trimester medical termination of pregnancy: an alternative for New Zealand women.
    Goodyear-Smith F; Knowles A; Masters J
    Aust N Z J Obstet Gynaecol; 2006 Jun; 46(3):193-8. PubMed ID: 16704471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medication Abortion Up to 70 Days of Gestation: ACOG Practice Bulletin Summary, Number 225.
    Obstet Gynecol; 2020 Oct; 136(4):855-858. PubMed ID: 32976374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acceptability of misoprostol-only medical termination of pregnancy compared with vacuum aspiration: an international, multicentre trial.
    Rodriguez MI; Seuc A; Kapp N; von Hertzen H; Huong NT; Wojdyla D; Mittal S; Arustamyan K; Shah R;
    BJOG; 2012 Jun; 119(7):817-23. PubMed ID: 22432980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methods for induced abortion.
    Stubblefield PG; Carr-Ellis S; Borgatta L
    Obstet Gynecol; 2004 Jul; 104(1):174-85. PubMed ID: 15229018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promoting or Undermining Quality Decision Making? A Qualitative Content Analysis of Patient Decision Aids Comparing Surgical and Medication Abortion.
    Donnelly KZ; Elwyn G; Theiler R; Thompson R
    Womens Health Issues; 2019; 29(5):414-423. PubMed ID: 31266679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness analysis of alternative first-trimester pregnancy termination strategies in Mexico City.
    Hu D; Grossman D; Levin C; Blanchard K; Goldie SJ
    BJOG; 2009 May; 116(6):768-79. PubMed ID: 19432565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pilot study on the use of letrozole with either misoprostol or mifepristone for termination of pregnancy up to 63 days.
    Lee VC; Tang OS; Ng EH; Yeung WS; Ho PC
    Contraception; 2011 Jan; 83(1):62-7. PubMed ID: 21134505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ob/Gyn training in abortion care: results from a national survey.
    Jackson CB; Foster AM
    Contraception; 2012 Oct; 86(4):407-12. PubMed ID: 22560184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An outpatient regimen of combined oral mifepristone 400 mg and misoprostol 400 microg for first-trimester legal medical abortion.
    Ravn P; Rasmussen A; Knudsen UB; Kristiansen FV
    Acta Obstet Gynecol Scand; 2005 Nov; 84(11):1098-102. PubMed ID: 16232179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of mifepristone and sublingual misoprostol for early medical abortion.
    Lin M; Li YT; Chen FM; Wu SF; Tsai CW; Chen TH; Kuo TC
    Taiwan J Obstet Gynecol; 2006 Dec; 45(4):321-4. PubMed ID: 17175490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.